Skip to content

Equinox Personal Coaching Versus Self-Directed Exercise

Effectiveness of Equinox Fitness Club's Personal Coaching Method Versus Self-Directed Exercise Training on Increasing Lean Body Mass in Men Aged 30-44 Years of Age

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01778153
Enrollment
43
Registered
2013-01-29
Start date
2012-01-31
Completion date
2012-12-31
Last updated
2016-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Fitness

Keywords

Fitness training, Personal training

Brief summary

The purpose of this study is to compare the Equinox Personal Coaching exercise training method to self-directed exercise training in helping subjects become more fit. Men between 30 and 44 years of age who exercise on a regular basis and are interested in receiving Equinox personal training will be invited to participate. The investigators will enroll 36 subjects at University of California, Los Angeles (UCLA), the only site. The hypothesis of this study is that subjects randomized to the Personal Coaching Method will result in significantly greater lean mass accrual than those randomized to self-directed training over the 12 weeks of the study. Subjects will have 2 Baseline visits over 1 week, then be randomized to receive either Coached training or self-training, which they will do for 12 weeks, then complete two End of Study visits over the final week. Visits 1 and 3 include questionnaires, skinfold fat/lean body mass measurements, and strength and aerobic performance tests, and will take place at Equinox. Visits 2 and 4 include a DEXA scan and ECG, which will take place at UCLA.

Interventions

BEHAVIORALEquinox Personal Coaching

Specially designed strength and aerobic exercise training program that consists of 36 sessions over 12 weeks.

Sponsors

Equinox Fitness Centers
CollaboratorUNKNOWN
University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
30 Years to 44 Years
Healthy volunteers
Yes

Inclusion criteria

* Men aged 30-44 years * Body mass index less than 30 kg/m2. * Currently exercising with or without coaching more than 4 days but less than 8 days per month for the past three months (Equinox Motivated or Super Motivated categories); * Willing to commit to 12 weeks of thrice weekly training at the Century City Equinox club with or without an Equinox coach.

Exclusion criteria

* Over age 44 * Musculoskeletal conditions limiting participation * Unstable cardiovascular, pulmonary, metabolic, or other disorders that would preclude high intensity exercise training. * Abnormal ECG at Screening that indicates the subject is not healthy enough for maximal exercise in the opinion of the principal investigator * Family history of sudden death associated with exercise, based on self-report

Design outcomes

Primary

MeasureTime frameDescription
Change in lean body massBaseline and 4 monthsChange in lean body mass (LBM) as measured by dual-energy x-ray absorptiometry (DEXA)

Secondary

MeasureTime frameDescription
Change in quality of lifeBaseline and 4 monthsA quality of life scale will also used to determine participant's satisfaction with their training and its result.
Change in muscle strengthBaseline and 4 monthsChanges in muscle strength in the upper and lower extremities as assessed with standard one-repetition maximum tests for the chest press and leg press exercises, respectively
Change in aerobic performanceBaseline and 4 monthsAerobic performance as assessed using a symptom-limited, treadmill ramp protocol.
Changes in ventilation and respiratory gas exchangeBaseline and 4 monthsMeasures of ventilation and respiratory gas exchange including changes in maximum oxygen uptake, the metabolic (lactate) threshold, and other parameters of aerobic, cardiovascular, and ventilatory fitness.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026